Johnson & Johnson Innovation (JJDC) is the strategic venture capital arm of Johnson & Johnson, focusing on investments in pharmaceuticals, medical devices, and consumer health that align with the parent company's scientific objectives and core business areas. Their strategy involves fostering breakthrough technologies to address unmet medical needs, taking a long-term investment view across all stages from early-stage startups to later rounds, and leveraging Johnson & Johnson's extensive capabilities to support portfolio companies.
Portfolio
3
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| MedCrypt, Inc. | Series B | $25M | Nov 2022 |
| Iterative Scopes | Series A | $30M | Aug 2021 |
| Stix | Seed | $1.3M | — |
Top Co-Investors
BDMI1 shared
Intuitive Ventures1 shared
Section 321 shared
Eniac Ventures1 shared
Anzu Partners1 shared
Dolby Family Ventures1 shared
Obvious Ventures1 shared
Eli Lilly1 shared
Breyer Capital1 shared
Time BioVentures1 shared
Last updated: 3 March 2026